PolyNovo Limited (ASX:PNV)
Australia
· Delayed Price · Currency is AUD 0.875
-0.065 (-6.91%)
At close: Mar 9, 2026
PolyNovo Revenue
PolyNovo had revenue of 70.33M AUD in the half year ending December 31, 2025, with 49.05% growth. This brings the company's revenue in the last twelve months to 139.49M, up 20.69% year-over-year. In the fiscal year ending June 30, 2025, PolyNovo had annual revenue of 128.70M with 24.67% growth.
Revenue (ttm)
139.49M
Revenue Growth
+20.69%
P/S Ratio
4.33
Revenue / Employee
463.43K
Employees
301
Market Cap
604.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 128.70M | 25.47M | 24.67% |
| Jun 30, 2024 | 103.23M | 37.56M | 57.20% |
| Jun 30, 2023 | 65.67M | 23.78M | 56.76% |
| Jun 30, 2022 | 41.89M | 12.55M | 42.78% |
| Jun 30, 2021 | 29.34M | 7.15M | 32.19% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anteris Technologies Global | 2.87M |
| Lumos Diagnostics Holdings | 18.31M |
| Aroa Biosurgery | 79.26M |
| 4DMedical | 5.81M |
| EMVision Medical Devices | 5.43M |
| SomnoMed | 118.50M |
| Cleo Diagnostics | 2.56M |
| Compumedics | 58.49M |
PolyNovo News
- 17 days ago - PolyNovo Limited (CALZF) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 4 months ago - PolyNovo Limited (CALZF) Shareholder/Analyst Call Transcript - Seeking Alpha